Filing Details
- Accession Number:
- 0001415889-25-018294
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-26 18:04:57
- Reporting Period:
- 2025-06-24
- Filing Date:
- 2025-06-26
- Accepted Time:
- 2025-06-26 18:04:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1484565 | Soleno Therapeutics Inc | SLNO | Electromedical & Electrotherapeutic Apparatus (3845) | 770523891 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1766042 | C Patricia Hirano | 100 Marine Parkway, Suite 400 Redwood City CA 94065 | See Remarks | No | No | No | No |
Transaction Summary
| Sold: | 266 shares | Avg. Price: $84.25 | Total Value: $22,410.50 |
| Number of Shares After Transactions: | 17,036 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-24 | 266 | $44.25 | 17,302 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-24 | 266 | $84.25 | 17,036 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee stock option (right to buy) | Disposition | 2025-06-24 | 266 | $0.00 | 266 | $44.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-04-19 | No | 4 | M | Direct |
Footnotes
- The option exercise and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person September 13, 2024
- Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- The number of shares beneficially owned has been decreased by 10,000 shares pursuant to an internal review of the Reporting Person's holdings.
- All of the shares subject to this option are fully vested and exercisable as of the date hereof.
Billionaire Hedge Funds
